bibliographicCitation |
Vo MN, Evans M, Leitzel K, Ali SM, Wilson M, Demers L, Evans DB, Lipton A. Elevated plasma endoglin (CD105) predicts decreased response and survival in a metastatic breast cancer trial of hormone therapy. Breast Cancer Research and Treatment. 2008 Dec 30;119(3):767–71. doi: 10.1007/s10549-008-0261-5. |